Eric I. Marks
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Peptidase Inhibition and Analysis
-
- Cell Adhesion Molecules Research
Papers in
- Oncology 8
- Colorectal Cancer Treatments and Studies 3
- Peptidase Inhibition and Analysis 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- D E Townsend (1 shared paper)Richart Rm (1 shared paper)Nelson S. Yee (1 shared paper)Don Steven Dizon (2 shared papers)Kim E. Leitzel (1 shared paper)Allan Lipton (1 shared paper)Nicholas Willumsen (1 shared paper)Sajid Ali (1 shared paper)
- Journals
- Cancer Biology & Therapy (2 papers)Blood (1 paper)Current Cancer Drug Targets (1 paper)Oncotarget (1 paper)Laboratory Investigation (1 paper)
- Partner nations
- United StatesDenmarkIndia
In The Last Decade
Eric I. Marks
13 papers receiving 301 citations
Peers
Comparison fields: 5 of 51
- Oncology 110
- Immunology and Allergy 22
- Cancer Research 47
- Obstetrics and Gynecology 22
- Epidemiology 70
Countries citing papers authored by Eric I. Marks
This map shows the geographic impact of Eric I. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric I. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric I. Marks more than expected).
Fields of papers citing papers by Eric I. Marks
This network shows the impact of papers produced by Eric I. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric I. Marks. The network helps show where Eric I. Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric I. Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Invasive cancer following outpatient evaluation and therapy for cervical disease. | 1981 | 76 |
| 2 | 2018 | 51 | |
| 3 | 2016 | 50 | |
| 4 | 2015 | 43 | |
| 5 | 2019 | 20 | |
| 6 | 2015 | 19 | |
| 7 | 2015 | 16 | |
| 8 | 2019 | 13 | |
| 9 | 2020 | 8 | |
| 10 | 2014 | 6 | |
| 11 | 2015 | 5 | |
| 12 | 2025 | 4 | |
| 13 | 2019 | 3 |
About Eric I. Marks
Eric I. Marks is a scholar working on Oncology, Hepatology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 13 papers that have together received 314 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Mechanisms and Therapy (2 papers), Sarcoma Diagnosis and Treatment (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer Research and Treatments (1 paper) and Ovarian cancer diagnosis and treatment (1 paper). The work is most often cited by research in Oncology (110 citations), Immunology and Allergy (22 citations), Cancer Research (47 citations), Obstetrics and Gynecology (22 citations) and Epidemiology (70 citations). Eric I. Marks has collaborated with scholars based in United States, Denmark and India. Frequent co-authors include D E Townsend, Richart Rm, Nelson S. Yee, Don Steven Dizon, Kim E. Leitzel, Allan Lipton, Nicholas Willumsen, Sajid Ali, Wafik S. El‐Deiry and M.A. Karsdal. Their work appears in journals such as Cancer Biology & Therapy, Blood, Current Cancer Drug Targets, Oncotarget and Laboratory Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.